Abstract

Drug-resistant bacteria are a global health concern owing to the high morbidity and mortality they can cause, especially in countries such as India. Gram-negative bacteria, including Enterobacteriaceae, Pseudomonas, and Acinetobacter, are primarily responsible for expanding the scope of drug resistance. These antibiotic-resistant pathogens are particularly associated with serious infections in hospitals. The production of carbapenemase by gram-negative bacteria appears to be the major reason for their resistance to carbapenems. The study was a prospective study done from March 2018 to December 2020. All the carbapenem-resistant isolates from various clinical samples were further tested for the production of carbapenemases/metallo-beta-lactamases production by various phenotypic tests like carbaNp, Imipenem–EDTA combined disc synergy test, Double-disc synergy test and E-test methods. Of all carbapenem-resistant gram-negative bacteria isolated from patients in a hospital in India, 237 (88.1%) carbapenemase producers were identified, among which 217 (91.5%) were metallo-beta-lactamase (MBL) producers. Therefore, the detection of MBL producers is important for preventing their infectious spread. The present study revealed that most MBL producers were isolated from patients of 0–9 to years of age (63.9%). The double-disc synergy test (DDST) and E-test MBL strips were more sensitive than the combined disc test in detecting MBLs. Because the DDST was the simplest and most effective method, it can be used for the routine laboratory screening of MBL producers in hospitals.

Highlights

  • All the carbapenem-resistant isolates from various clinical samples were further tested for the production of carbapenemases/metallo-beta-lactamases production by various phenotypic tests like carbaNp, Imipenem–ethylenediamine tetra acetic acid (EDTA) combined disc synergy test, Double-disc synergy test and E-test methods

  • Of all carbapenem-resistant gram-negative bacteria isolated from patients in a hospital in India, 237 (88.1%) carbapenemase producers were identified, among which 217 (91.5%) were metallo-betalactamase (MBL) producers

  • The expansion and spread of multi drug-resistant gram-negative bacteria (GNB) is a major public health concern worldwide owing to the high morbidity and mortality that can result from infections by such pathogens, especially in India.[1]

Read more

Summary

Introduction

The expansion and spread of multi drug-resistant gram-negative bacteria (GNB) is a major public health concern worldwide owing to the high morbidity and mortality that can result from infections by such pathogens, especially in India.[1] These non-susceptible bacteria are associated with serious hospitalacquired infections, known as nosocomial infections.[1]. Owing to the paucity of available therapeutic options, antimicrobial resistance has become one of the greatest public health concerns, with the incidence of complications associated with multidrug-resistant GNB increasing worldwide

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call